Behavioral Approaches to CDH: Evidence and Outcomes

  • Shalonda S. SlaterEmail author
  • Hope L. O’Brien


Non-pharmacological options for the management of chronic daily headache are of increasing interest to patients and providers given the high cost of prescription medication, poor efficacy, and concern for potential side effects. Options include behavioral approaches, relaxation techniques, and lifestyle modification, which can be used alone or in conjunction with traditional pharmaceutical therapies. The goals of a behavioral approach are to increase functioning and minimize disability related to chronic pain and should be taught or administered by a trained professional. Lifestyle modification involves educating the patient about the importance of maintaining a healthy balanced diet rich in vegetables, without skipping meals, staying hydrated, practicing good sleep hygiene, incorporating regular exercise, and avoiding caffeine and other potential triggers. This chapter focuses on the evidence that supports current practice recommendations for managing chronic daily headache and highlights limitations where further research is warranted.


Cognitive behavioral therapy Relaxation Mindfulness Lifestyle modification Healthy habits Triggers 


  1. 1.
    Penzien DB, Irby MB, Smitherman TA, Rains JC, Houle TT. Well established and empirically supported behavioral treatments for migraine. Curr Pain Headache Rep. 2015;19:34.CrossRefPubMedGoogle Scholar
  2. 2.
    Faedda N, Cerutti R, Verdecchia P, Migliorini D, Arruda M, Guidetti V. Behavioral management of headache in children and adolescents. J Head Pain. 2016;17:80.CrossRefGoogle Scholar
  3. 3.
    Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards Subcommittee of the American Academy of neurology. Neurology. 2000;55(6):754–62.CrossRefPubMedGoogle Scholar
  4. 4.
    Drossman DA. Gastrointestinal illness and the biopsychosocial model. Psychosom Med. 1998;60:258–67.CrossRefPubMedGoogle Scholar
  5. 5.
    Melzack R, Wall PD. Pain mechanisms: a new theory. Surv Anesthesiol. 1967;11(2):89–90.CrossRefGoogle Scholar
  6. 6.
    Fraser F, Matsuzawa Y, Lee YSC, Minen M. Behavioral treatments for post-traumatic headache. Curr Pain Headache Rep. 2017;21(5):22.CrossRefPubMedGoogle Scholar
  7. 7.
    Cho SJ, Song TJ, Chu MK. Treatment update of chronic migraine. Curr Pain Headache Rep. 2017;21(6):26.CrossRefPubMedGoogle Scholar
  8. 8.
    Nestoriuc Y, Rief W, Andrasik F. Biofeedback treatment for headache disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback. 2008;33(3):125–40.CrossRefPubMedGoogle Scholar
  9. 9.
    Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass SJ, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache. 2002;42(6):483–90.CrossRefPubMedGoogle Scholar
  10. 10.
    Rausa M, Palomba D, Cevoli S, Lazzerini L, Sancisi E, Cortelli P, et al. Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial. J Headache Pain. 2016;17(1):87.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Sullivan A, Cousins S, Ridsdale L. Psychological interventions for migraine: a systematic review. J Neurol. 2016;263(12):2369–77.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Harris P, Loveman E, Clegg A, Easton S, Berry N. Systematic review of cognitive behavioural therapy for the management of headaches and migraines in adults. Br J Pain. 2015;9:213–24.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Holroyd KA, Cottrell CK, O’Donnell FJ, et al. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ. 2010;341:c4871.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Powers SW, Kashikar-Zuck SM, Allen JR, LeCates SL, Slater SK, Zafar M, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013;310(24):2622–30.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Kroner JW, Hershey AD, Kashikar-Zuck SM, LeCates SL, Allen JR, Slater SK, et al. Cognitive behavioral therapy plus amitriptyline for children and adolescents with chronic migraine reduces headache days to ≤ 4 per month. Headache. 2016;56(4):711–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Andrasik F, Grazzi L, D'Amico D, Sansone E, Leonardi M, Raggi A, et al. Mindfulness and headache: a “new”old treatment, with new findings. Cephalalgia. 2016;36(12):1192–205.CrossRefPubMedGoogle Scholar
  17. 17.
    Tepper SJ. Nutraceutical and other modalities for the treatment of headache. Continuum (Minneap Minn). 2015;21(4):1018–31.Google Scholar
  18. 18.
    Orr SL. Diet and nutraceutical interventions for headache management: a review of the evidence. Cephalalgia. 2016;36(12):1112–33.CrossRefPubMedGoogle Scholar
  19. 19.
    Murray KA, O’Neal KS, Weisz M. Dietary suggestions for migraine preventions. Am J Health Sys Pharm. 2015;72(7):519–21.CrossRefGoogle Scholar
  20. 20.
    Sandor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64:713–5.CrossRefPubMedGoogle Scholar
  21. 21.
    Hershey AD, Powers SW, Vockell A-LB, et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache. 2007;47:73–80.CrossRefPubMedGoogle Scholar
  22. 22.
    Mody I, Lambert JD, Heinemann U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol. 1987;57(3):869–88.CrossRefPubMedGoogle Scholar
  23. 23.
    Altura BT, Altura BM. Withdrawal of magnesium causes vasospasm while elevated magnesium produces relaxation of tone in cerebral arteries. Neurosci Lett. 1980;20(3):323–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Weglicki WB, Phillips TM. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Phys. 1992;263(3 pt 2):R734–7.Google Scholar
  25. 25.
    Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16(4):257–63.CrossRefGoogle Scholar
  26. 26.
    Pfaffenrath V, WEsseley P, Meyer C, Isler HR, Evers S, Grotemeyer KH, et al. Magnesium in the prophylaxis of migraine-a double=blind placebo-controlled study. Cephalalgia. 1996;16(6):436–40.CrossRefGoogle Scholar
  27. 27.
    Bianchi A, Salomone S, Caraci F, Pizza V, Bernardina R, D’Amato CC. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitam Horm. 2004;69:297–312.CrossRefPubMedGoogle Scholar
  28. 28.
    Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intervenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia. 2002;22(5):345–53.CrossRefPubMedGoogle Scholar
  29. 29.
    O’Brien HL, Hershey AD. Vitamin s and paediatric migraine: riboflavin as a preventative medication. Cephalalgia. 2010;30(12):1417–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998;50:466–70.CrossRefPubMedGoogle Scholar
  31. 31.
    Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44:885–90.CrossRefPubMedGoogle Scholar
  32. 32.
    Rajapakse R, Pringsheim T. Nutraceuticals in migraine: a summary of existing guidelines for use. Headache. 2016;56(4):808–16.CrossRefPubMedGoogle Scholar
  33. 33.
    Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67(2):252–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Bic Z, Blix G, Hopp H, et al. The influence of a low-fat diet on incidence and severity of migraine headaches. J Womens Health Gend Based Med. 1999;8:623–30.CrossRefPubMedGoogle Scholar
  35. 35.
    Bunner AE, Agarwal U, Gonzales JF, et al. Nutrition intervention for migraine: a randomized crossover trial. J Headache Pain. 2014;15:1–9.CrossRefGoogle Scholar
  36. 36.
    Arroyave Hernandez C, Echavarria Pinto M, Hernandez Montiel HL. Food allergy mediated by IgG antibodies associated with migraine in adults. Rev Alerg Mex. 2007;54:162–8.PubMedGoogle Scholar
  37. 37.
    Alpay K, Ertax M, Orhan EH, et al. Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomized, cross-over trial. Cephalalgia. 2010;30:829–37.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Barborka CJ. Migraine: results of treatment by ketogenic diet in fifty cases. JAMA. 1930;95:1825–8.CrossRefGoogle Scholar
  39. 39.
    Kossoff EH, Huffman J, Turner Z, et al. Use of the modified Atkins diet for adolescents with chronic daily headache. Cephalalgia. 2010;30:1014–6.PubMedGoogle Scholar
  40. 40.
    Dexter J, Roerts J, Byer J. The five hour glucose tolerance test and effect of low sucrose diet in migraine. Headache. 1978;18:91–4.CrossRefPubMedGoogle Scholar
  41. 41.
    Ramsden C, Faurot K, Zamora D, Suchindran CM, Macintosh BA, Gaylord S, et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain. 2013;154:1–22.CrossRefGoogle Scholar
  42. 42.
    Peris F, Donoghue S, Torres F, Mian A, Wober C. Towards improved migraine management: determining potential trigger factors in individual patients. Cephalalgia. 2016;37(5):452–63.CrossRefPubMedGoogle Scholar
  43. 43.
    Martins IP, Gouveia RG. More on water and migraine. Cephalalgia. 2007;27:372–4.CrossRefPubMedGoogle Scholar
  44. 44.
    Carvalho GF, Chaves TC, Dach F, Pinheiro CF, Goncalves MC, Florencio LL, Ferreira KS, Bigal ME, Bevilaqua-Grossi D. Influence of migraine and migraine aura on balance and mobility - a controlled study. Headache. 2013;53:1116–22.CrossRefPubMedGoogle Scholar
  45. 45.
    Blau JN, Kell CA, Sperling JM. Water-deprivation headache: a new headache with two variants. Headache. 2004;44:79–83.CrossRefPubMedGoogle Scholar
  46. 46.
    Sun-Edelstein C, Mauskop A. Foods and supplements in the management of migraine headaches. Clin J Pain. 2009;25(5):446–52.CrossRefPubMedGoogle Scholar
  47. 47.
    Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394–402.CrossRefPubMedGoogle Scholar
  48. 48.
    Ravishankar K, Evans RW, Wang S-J. Modern day management of headache questions and answers. New Delhi: The Health Sciences Publishers; 2017.Google Scholar
  49. 49.
    Matthew N, Tfelt-Hansen P. General and pharmacologic approach to migraine management. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. p. 433–40.Google Scholar
  50. 50.
    Busch W, Gaul C. Exercise in migraine therapy-is there any evidence for efficacy? A critical review. Headache. 2008;48:890–9.CrossRefPubMedGoogle Scholar
  51. 51.
    Lockett DM, Campbell JF. The effects of aerobic exercise on migraine. Headache. 1992;32:50–4.CrossRefPubMedGoogle Scholar
  52. 52.
    Nordlander E, Cider A, Carlsson J, Linde M. Improvement of exercise capacity in patients with migraine–methodological considerations. Cephalalgia. 2007;27:575–9.CrossRefGoogle Scholar
  53. 53.
    Zheng Y, Tepper SJ, Covington EC, Mathews M, Scheman J. Retrospective outcome analysis for headache in a pain rehabilitation interdisciplinary program. Headache. 2014;54:520–7.CrossRefPubMedGoogle Scholar
  54. 54.
    Sahota PK, Dexter JD. Sleep and headache syndromes: a clinical review. Headache. 1990;30:80–4.CrossRefPubMedGoogle Scholar
  55. 55.
    Jennum P, Jensen R. Sleep and headache. Sleep Med Rev. 2002;6:471–9.CrossRefPubMedGoogle Scholar
  56. 56.
    Gilman DK, Palermo TM, Kabbouche MA, Hershey AD, Powers SW. Primary headache and sleep disturbances in adolescents. Headache. 2007;47:1189–94.CrossRefPubMedGoogle Scholar
  57. 57.
    Calhoun AH, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache. 2007;47:1178–83.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Behavioral Medicine and Clinical Psychology, Department of PediatricsCincinnati Children’s Hospital Medical Center, University of Cincinnati College of MedicineCincinnatiUSA
  2. 2.Division of Neurology, Department of PediatricsCincinnati Children’s Hospital Medical Center, University of Cincinnati College of MedicineCincinnatiUSA

Personalised recommendations